Chatterton & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-943
Closed -$244K – 110
2026
Q2
$244K Buy
943
+12
+1% +$2.8K 0.14% 92
2026
Q1
$225K Buy
+931
New +$217K 0.16% 90

Other funds holding JNJ

Chatterton & Associates's JNJ Position: Q3 2026 in Review

Chatterton & Associates sold out of Johnson & Johnson (JNJ) in Q3 2026, closing a stake of 943 shares — an estimated $244K sold.

Chatterton & Associates first reported a position in JNJ in Q1 2026 and held it in 2 quarters. The position peaked at $244K in Q2 2026. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Chatterton & Associates reported no remaining Johnson & Johnson position as of Q3 2026 after selling out during the quarter.
  • Chatterton & Associates sold 943 Johnson & Johnson shares in Q3 2026, an estimated $244K.
  • Chatterton & Associates first reported a position in Johnson & Johnson in Q1 2026 and held it in 2 quarters.
  • Chatterton & Associates's Johnson & Johnson position peaked at $244K in Q2 2026.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Chatterton & Associates's 13F filing for Q3 2026, filed 12 Nov 2026.